| Name | Title | Contact Details |
|---|---|---|
Melanie Gill |
Senior Director, Global Strategic Account Management, R&D Solutions | Profile |
Brenda Wagner |
Vice President - Global Talent | Profile |
Steve Rauschkolb |
Director - Training and Development - Commercial | Profile |
Jenny Sharp |
Senior Director - Human Resources | Profile |
Lisa van Capelle |
Acting Chief Human Resources Officer and Vice President of Global Human Resources | Profile |
Regenacy Pharmaceuticals is developing a novel, disease-modifying approach to treating peripheral neuropathies that goes beyond pain and symptom management to restore peripheral nerve function.
Avail Scientific is working to facilitate a medical and social revolution of the current pharmacological therapies for addiction and the underlying causes by providing evidence-based diagnostic and data acquisition programs. These substances can be used as both treatment for addiction and as preventative therapy by addressing the health challenges underlying substance abuse. We are building a platform to both educate and equip healthcare professionals with the data to use these therapeutic tools efficiently. Our objective is to treat this medical condition and prove out rehabilitation and preventative therapy programs with our partners in healthcare communities, both local and globally. Avail Scientific is positioned to become a global leader in eliminating the needless suffering that surrounds addiction and mental health issues by providing effective data and patient monitoring to validate their efficacy.
Our patented and award-winning Highlight® technology makes it easy to use disinfectants correctly.
Pathogen Detection Systems, Inc. is a Thunder Bay, ON-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
IGM Biosciences, Inc. is a privately held biotechnology company that has been focused on creating and developing novel IgM and IgA antibodies that improve the treatment of cancer and other diseases since 2010.